Skip to main content

and
  1. Article

    Open Access

    New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination

    Vaccination with a coronavirus disease-2019 (COVID-19) vaccine is an effective public health measure for reducing the risk of infection and severe complications from COVID-19. However, serious hematological co...

    Mirei Kobayashi, Akio Mori, Yoshitaka Oda in International Journal of Hematology (2023)

  2. Article

    Open Access

    Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma

    Serologic responses of COVID-19 vaccine are impaired in patients with B-cell lymphoma, especially those who had recently been treated with anti-CD20 monoclonal antibodies. However, it is still unclear whether ...

    Takashi Ishio, Shihori Tsukamoto, Emi Yokoyama, Koh Izumiyama in Annals of Hematology (2023)

  3. Article

    Open Access

    Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms

    Patients with lymphoid malignancies have impaired humoral immunity caused by the disease itself and its treatment, placing them at risk for severe coronavirus disease-19 (COVID-19) and reduced response to vacc...

    Mirei Kobayashi, Akio Mori, Masahiro Onozawa, Shihori Tsukamoto in Annals of Hematology (2023)